Literature DB >> 10368227

Prognostic factors in renal cell and bladder cancer.

J P Van Brussel1, G H Mickisch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10368227     DOI： 10.1046/j.1464-410x.1999.00120.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  12 in total

1.  Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer.

Authors:  Andreas Eisenhardt; Winfried Siffert; Dieter Rosskopf; Michael Musch; Max Mosters; Ulla Roggenbuck; Karl-Heinz Jöckel; Herbert Rübben; Gerd Lümmen
Journal:  World J Urol       Date:  2005-11-08       Impact factor: 4.226

2.  Molecular aspects of renal cell carcinoma: a review.

Authors:  Hari Koul; Jung-Sik Huh; Kyle O Rove; Luiza Crompton; Sweaty Koul; Randall B Meacham; Fernando J Kim
Journal:  Am J Cancer Res       Date:  2010-12-18       Impact factor: 6.166

3.  Factors impacting survival in children with renal cell carcinoma.

Authors:  Kristy L Rialon; Brian C Gulack; Brian R Englum; Jonathan C Routh; Henry E Rice
Journal:  J Pediatr Surg       Date:  2015-03-14       Impact factor: 2.545

4.  Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor.

Authors:  T J Harvey; D Burdon; L Steele; N Ingram; G D Hall; P J Selby; R G Vile; P A Cooper; S D Shnyder; J D Chester
Journal:  Gene Ther       Date:  2010-04-22       Impact factor: 5.250

5.  Expression of transforming growth factor beta in renal cell carcinoma and matched non-involved renal tissue.

Authors:  Dionisios Mitropoulos; Aspasia Kiroudi; Evangelia Christelli; Efraim Serafetinidis; Anastasios Zervas; Ioannis Anastasiou; Constantinos Dimopoulos
Journal:  Urol Res       Date:  2004-09-07

6.  Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.

Authors:  Pierpaolo Alongi; Maria Picchio; Fabio Zattoni; Marianna Spallino; Luigi Gianolli; Giorgio Saladini; Laura Evangelista
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-14       Impact factor: 9.236

7.  Association between microvessel density and histologic grade in renal cell carcinomas.

Authors:  Nikolaos Kavantzas; Helen Paraskevakou; Sofia Tseleni-Balafouta; Kyriaki Aroni; Pauline Athanassiades; George Agrogiannis; Efstratios Patsouris
Journal:  Pathol Oncol Res       Date:  2007-07-03       Impact factor: 3.201

8.  Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder.

Authors:  Jian-Ye Liu; Yong-Hong Li; Huan-Xin Lin; Yi-Ji Liao; Shi-Juan Mai; Zhou-Wei Liu; Zhi-Ling Zhang; Li-Juan Jiang; Jia-Xing Zhang; Hsiang-Fu Kung; Yi-Xin Zeng; Fang-Jian Zhou; Dan Xie
Journal:  BMC Cancer       Date:  2013-07-19       Impact factor: 4.430

9.  Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma.

Authors:  Jae Young Choi; Young Hwii Ko; Phil Hyun Song
Journal:  Investig Clin Urol       Date:  2016-08-09

10.  Impact of preoperative thrombocytosis on prognosis after surgical treatment in pathological T1 and T2 renal cell carcinoma: results of a multi-institutional comprehensive study.

Authors:  Yun-Sok Ha; Jae-Wook Chung; So Young Chun; Seock Hwan Choi; Jun Nyung Lee; Bum Soo Kim; Hyun Tae Kim; Tae-Hwan Kim; Seok-Soo Byun; Eu Chang Hwang; Seok Ho Kang; Sung-Hoo Hong; Jinsoo Chung; Cheol Kwak; Yong-June Kim; Tae Gyun Kwon
Journal:  Oncotarget       Date:  2017-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.